-
Johnson & Johnson: How To Cope With Market Risk
Post on 10/18/16
-
How Johnson & Johnson Could Plummet To $98
Post on 10/18/16
-
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Post on 10/18/16
-
3 Reasons Pfizer Is A Screaming Buy Right Now
Post on 10/18/16
-
Better Buy: Ionis Pharmaceuticals, Inc. vs. Celgene
Post on 10/18/16
-
Hillary Clinton vs. Donald Trump on Medicare
Post on 10/17/16
-
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
Post on 10/17/16
-
3 Figures That Matter Most When Johnson & Johnson Reports Its 3rd-Quarter Results
Post on 10/17/16
-
Why These Top Hedge Funds Love Priceline Group And Pfizer
Post on 10/17/16
-
PA Biotechnology Center to Begin $10 Million Expansion
Post on 10/16/16
-
Watch Out, AbbVie: Johnson & Johnson Is Nipping at Your Heels
Post on 10/14/16
-
Geisinger Selected to Join the national Precision Medicine Initiative
Post on 10/13/16
-
PANTHERx Specialty Pharmacy Ranked #5 Best Place to Work by Modern Healthcare in 2016
Post on 10/13/16
-
Pernix Therapeutics Announces Reverse Stock Split and Corporate Governance Enhancements
Post on 10/13/16
-
Is Immunomedics Inc. Still a Strong Buy?
Post on 10/13/16
-
Pfizer's Growth Strategies May Need More Than Just Small Acquisitions
Post on 10/13/16
-
Can Johnson & Johnson Keep Growing Healthier?
Post on 10/13/16
-
Health Partners Plans Among Top 15 Medicaid MCOs in the Country
Post on 10/12/16
-
Celgene and Agios Announce Collaborations with Abbott
Post on 10/12/16
-
Health Partners Plans Among Top 15 Medicaid MCOs in the Country
Post on 10/12/16
-
Immunomedics Closes $30 Million Financing
Post on 10/12/16
-
Delaware Valley ACO Renews Value-Based Contract with Humana
Post on 10/11/16
-
Better Buy: Biogen vs. Celgene
Post on 10/10/16
-
Alliqua BioMedical Announces Expansion of Medicare Reimbursement Coverage for MIST Therapy
Post on 10/10/16
-
Nexus BioPharma Announces Agreement with TransChem
Post on 10/8/16
Philadelphia
